Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1996;93:23-26

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jacobsen, A. N.
Right arrow Articles by Woodcock, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jacobsen, A. N.
Right arrow Articles by Woodcock, E. A.

(Circulation. 1996;93:23-26.)
© 1996 American Heart Association, Inc.


Articles

Arrhythmogenic Action of Thrombin During Myocardial Reperfusion via Release of Inositol 1,4,5-Triphosphate

Alexander N. Jacobsen, BSc, MBBS; Xiao-Jun Du, MB, PhD; Kim A. Lambert, BSc; Anthony M. Dart, MRCP, PhD; Elizabeth A. Woodcock, PhD

From the Cellular Biochemistry Laboratory and Alfred and Baker Medical Unit, Baker Medical Research Institute, Melbourne, Australia.

Correspondence to Dr Alexander Jacobsen, Alfred and Baker Medical Unit, Baker Medical Research Institute, Commercial Rd, Prahran (Melbourne), Victoria 3181, Australia.

Background Cardiac reperfusion initiates release of inositol 1,4,5-triphosphate [Ins(1,4,5)P3] and arrhythmogenesis via norepinephrine stimulation of {alpha}1-adrenergic receptors. The present study examines arrhythmogenic effects of thrombin-stimulated Ins(1,4,5)P3 release under these conditions.

Methods and Results [3H]Ins(1,4,5)P3 release was measured in [3H]inositol-labeled rat hearts by high-performance liquid chromatography. Arrhythmia studies were performed in buffer-perfused rat hearts. Two-minute reperfusion after 20 minutes of global ischemia increased [3H]Ins(1,4,5)P3 from 1123±77 to 2238±44 cpm/mg tissue. No increase was observed in catecholamine-depleted hearts (755±89 cpm/mg). The addition of thrombin (5 IU/mL) or thrombin receptor agonist peptide (TRAP1-6, 50 µmol/L) restored the reperfusion Ins(1,4,5)P3 response (thrombin, 1518±68 cpm/mg and TRAP1-6, 1755±128 cpm/mg). Ins(1,4,5)P3 release initiated by norepinephrine or thrombin was inhibited by gentamicin (150 µmol/L; 986±52 and 868±125 cpm/mg, respectively). The thrombin response was inhibited by the phospholipase C inhibitor U-73122 (5 µmol/L; 394±59 cpm/mg) but not by its inactive isomer U-73343. The norepinephrine response was not inhibited by U-73122 (2126±74 cpm/mg). Ventricular tachycardia and ventricular fibrillation were observed in intact hearts but not in hearts from catecholamine-depleted rats (ventricular fibrillation duration, 110±19 versus 0±0 seconds). The addition of thrombin or TRAP1-6 increased arrhythmias in catecholamine-depleted hearts (112±32 and 89±28 seconds, respectively). Gentamicin and U-73122 but not U-73343 prevented thrombin-induced arrhythmias. Gentamicin inhibited norepinephrine-initiated arrhythmias, but U-73122 was ineffective.

Conclusions This study demonstrates that the development of reperfusion arrhythmias under these conditions depends on the release of Ins(1,4,5)P3.


Key Words: arrhythmia • enzymes • receptors, adrenergic, alpha • thrombin • inositol phosphates




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
M. J. Wacker, L. M. Kosloski, W. J. R. Gilbert, C. D. Touchberry, D. S. Moore, J. K. Kelly, M. Brotto, and J. A. Orr
Inhibition of Thromboxane A2-Induced Arrhythmias and Intracellular Calcium Changes in Cardiac Myocytes by Blockade of the Inositol Trisphosphate Pathway
J. Pharmacol. Exp. Ther., December 1, 2009; 331(3): 917 - 924.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. A. Woodcock, P. M. Kistler, and Y.-K. Ju
Phosphoinositide signalling and cardiac arrhythmias
Cardiovasc Res, May 1, 2009; 82(2): 286 - 295.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Pinet, V. Algalarrondo, S. Sablayrolles, B. Le Grand, C. Pignier, D. Cussac, M. Perez, S. N. Hatem, and A. Coulombe
Protease-Activated Receptor-1 Mediates Thrombin-Induced Persistent Sodium Current in Human Cardiomyocytes
Mol. Pharmacol., June 1, 2008; 73(6): 1622 - 1631.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. A. Lanzafame, L. Turnbull, F. Amiramahdi, J. F. Arthur, H. Huynh, and E. A. Woodcock
Inositol phospholipids localized to caveolae in rat heart are regulated by {alpha}1-adrenergic receptors and by ischemia-reperfusion
Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H2059 - H2065.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. Fauconnier, J. T. Lanner, S.-J. Zhang, P. Tavi, J. D. Bruton, A. Katz, and H. Westerblad
Insulin and Inositol 1,4,5-Trisphosphate Trigger Abnormal Cytosolic Ca2+ Transients and Reveal Mitochondrial Ca2+ Handling Defects in Cardiomyocytes of ob/ob Mice
Diabetes, August 1, 2005; 54(8): 2375 - 2381.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. F. Steinberg
The Cardiovascular Actions of Protease-Activated Receptors
Mol. Pharmacol., January 1, 2005; 67(1): 2 - 11.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. V. Zima and L. A. Blatter
Inositol-1,4,5-trisphosphate-dependent Ca2+ signalling in cat atrial excitation-contraction coupling and arrhythmias
J. Physiol., March 15, 2004; 555(3): 607 - 615.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. A. Woodcock, B. H. Wang, J. F. Arthur, A. Lennard, S. J. Matkovich, X.-J. Du, J. H. Brown, and R. D. Hannan
Inositol Polyphosphate 1-Phosphatase Is a Novel Antihypertrophic Factor
J. Biol. Chem., June 14, 2002; 277(25): 22734 - 22742.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
G. Vassort
Adenosine 5'-Triphosphate: a P2-Purinergic Agonist in the Myocardium
Physiol Rev, April 1, 2001; 81(2): 767 - 806.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. Duru, M. Barton, T. F. Luscher, and R. Candinas
Endothelin and cardiac arrhythmias: do endothelin antagonists have a therapeutic potential as antiarrhythmic drugs?
Cardiovasc Res, February 1, 2001; 49(2): 272 - 280.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
M. Jaconi, C. Bony, S. M. Richards, A. Terzic, S. Arnaudeau, G. Vassort, and M. Pucéat
Inositol 1,4,5-Trisphosphate Directs Ca2+ Flow between Mitochondria and the Endoplasmic/Sarcoplasmic Reticulum: A Role in Regulating Cardiac Autonomic Ca2+ Spiking
Mol. Biol. Cell, May 1, 2000; 11(5): 1845 - 1858.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. J. Matkovich and E. A. Woodcock
Ca2+-activated but Not G Protein-mediated Inositol Phosphate Responses in Rat Neonatal Cardiomyocytes Involve Inositol 1,4,5-Trisphosphate Generation
J. Biol. Chem., April 6, 2000; 275(15): 10845 - 10850.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
E. Carmeliet
Cardiac Ionic Currents and Acute Ischemia: From Channels to Arrhythmias
Physiol Rev, July 1, 1999; 79(3): 917 - 1017.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. A. Woodcock, N. Reyes, A. N. Jacobsen, and X.-J. Du
Inhibition of Inositol(1,4,5)Trisphosphate Generation by Endothelin-1 During Postischemic Reperfusion : A Novel Antiarrhythmic Mechanism
Circulation, February 16, 1999; 99(6): 823 - 828.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. N. Harrison, D. J. Autelitano, B. H. Wang, C. Milano, X.-J. Du, and E. A. Woodcock
Reduced Reperfusion–Induced Ins(1,4,5)P3 Generation and Arrhythmias in Hearts Expressing Constitutively Active {alpha}1B-Adrenergic Receptors
Circ. Res., December 14, 1998; 83(12): 1232 - 1240.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. A Woodcock, S. J Matkovich, and O. Binah
Ins(1,4,5)P3 and cardiac dysfunction
Cardiovasc Res, November 1, 1998; 40(2): 251 - 256.
[Full Text] [PDF]


Home page
Circ. Res.Home page
B. Felzen, M. Shilkrut, H. Less, I. Sarapov, G. Maor, R. Coleman, R. B. Robinson, G. Berke, and O. Binah
Fas (CD95/Apo-1)–Mediated Damage to Ventricular Myocytes Induced by Cytotoxic T Lymphocytes From Perforin-Deficient Mice : A Major Role for Inositol 1,4,5-Trisphosphate
Circ. Res., March 9, 1998; 82(4): 438 - 450.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. S. D. Nair, J. W. Leitch, J. Falconer, and M. L. Garg
Prevention of Cardiac Arrhythmia by Dietary (n-3) Polyunsaturated Fatty Acids and Their Mechanism of Action
J. Nutr., March 1, 1997; 127(3): 383 - 393.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. F. Arthur, S. J. Matkovich, C. J. Mitchell, T. J. Biden, and E. A. Woodcock
Evidence for Selective Coupling of alpha 1-Adrenergic Receptors to Phospholipase C-beta 1 in Rat Neonatal Cardiomyocytes
J. Biol. Chem., September 28, 2001; 276(40): 37341 - 37346.
[Abstract] [Full Text] [PDF]